A new combination for advanced multiple myeloma

Lancet Oncol. 2011 Mar;12(3):207-8. doi: 10.1016/S1470-2045(11)70036-5. Epub 2011 Feb 21.

Authors

Antonio Palumbo¹, Francesca Gay

Affiliation

¹ Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliera Universitaria (AOU) S Giovanni Battista, Torino, Italy. [email protected]

PMID: 21345727
DOI: 10.1016/S1470-2045(11)70036-5

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Agents / therapeutic use*
Boronic Acids / therapeutic use
Bortezomib
Drug Therapy, Combination
Humans
Multiple Myeloma / drug therapy*
Multiple Myeloma / pathology
Pyrazines / therapeutic use

Substances

Antineoplastic Agents
Boronic Acids
Pyrazines
Bortezomib